000 | 01922 a2200517 4500 | ||
---|---|---|---|
005 | 20250517130140.0 | ||
264 | 0 | _c20170526 | |
008 | 201705s 0 0 eng d | ||
022 | _a2168-6157 | ||
024 | 7 |
_a10.1001/jamaneurol.2016.4547 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShahnawaz, Mohammad | |
245 | 0 | 0 |
_aDevelopment of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. _h[electronic resource] |
260 |
_bJAMA neurology _cFeb 2017 |
||
300 |
_a163-172 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
650 | 0 | 4 | _aBiochemical Phenomena |
650 | 0 | 4 | _aDiagnostic Tests, Routine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLewy Body Disease _xcerebrospinal fluid |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMultiple System Atrophy _xcerebrospinal fluid |
650 | 0 | 4 | _aOutcome Assessment, Health Care |
650 | 0 | 4 |
_aParkinson Disease _xcerebrospinal fluid |
650 | 0 | 4 |
_aPeptide Fragments _xcerebrospinal fluid |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aProtein Aggregation, Pathological _xcomplications |
650 | 0 | 4 |
_aProteostasis Deficiencies _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aalpha-Synuclein _xcerebrospinal fluid |
650 | 0 | 4 |
_atau Proteins _xcerebrospinal fluid |
700 | 1 | _aTokuda, Takahiko | |
700 | 1 | _aWaragai, Masaaki | |
700 | 1 | _aMendez, Nicolas | |
700 | 1 | _aIshii, Ryotaro | |
700 | 1 | _aTrenkwalder, Claudia | |
700 | 1 | _aMollenhauer, Brit | |
700 | 1 | _aSoto, Claudio | |
773 | 0 |
_tJAMA neurology _gvol. 74 _gno. 2 _gp. 163-172 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaneurol.2016.4547 _zAvailable from publisher's website |
999 |
_c26667565 _d26667565 |